Welcome to our dedicated page for CNBX Pharms SEC filings (Ticker: CNBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
cannabics pharmaceuticals is dedicated to the development of advanced cannabinoid-based treatments and therapies. the company’s main focus is the development of novel therapies and biotechnological tools aimed to providing relief from diverse ailments and treat human malignancies. these advanced tools include novel delivery systems, personalized medicine diagnostics and therapies based on cannabinoid compounds. cannabics' research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on cutting edge high through-output screening and bioinformatic tools. the company’s principal product is cannabics sr, a long acting oil capsule that provides a safe, effective and reliable administration of cannabis. composed solely from food grade materials, cannabics sr 25mg delivers a steady level of beneficial effects for 10–12 hours . the once-per day oral dosing regimen offered by cannabics sr allows patients a more consistent therapeutic effect throughout theCNBX Pharmaceuticals (CNBX): Schedule 13G/A Amendment No. 6 filed by 3i, LP, 3i Management LLC, and Maier Joshua Tarlow reports beneficial ownership of 80,865,244 shares, representing 9.99% of CNBX common stock.
The position includes 24,600,000 shares held and 56,265,244 shares issuable upon conversion of a senior secured convertible note, subject to a 9.99% beneficial ownership limitation (the “Blocker”). CNBX had 753,196,666 shares outstanding as of September 30, 2025.
The reporting persons indicate shared voting and dispositive power over 80,865,244 shares and no sole power. They certify the securities are not held for the purpose of changing or influencing control of the issuer.
FAQ
What is the current stock price of CNBX Pharms (CNBX)?
What is the market cap of CNBX Pharms (CNBX)?
